MDGL logo

Madrigal Pharmaceuticals (MDGL) Depreciation and amortization

annual D&A:

$1.10M+$569.00K(+107.97%)
December 31, 2024

Summary

  • As of today (June 21, 2025), MDGL annual depreciation & amortization is $1.10 million, with the most recent change of +$569.00 thousand (+107.97%) on December 31, 2024.
  • During the last 3 years, MDGL annual D&A has risen by +$691.00 thousand (+170.62%).
  • MDGL annual D&A is now -70.01% below its all-time high of $3.65 million, reached on December 31, 2006.

Performance

MDGL Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

quarterly D&A:

$379.00K+$16.00K(+4.41%)
March 31, 2025

Summary

  • As of today (June 21, 2025), MDGL quarterly depreciation & amortization is $379.00 thousand, with the most recent change of +$16.00 thousand (+4.41%) on March 31, 2025.
  • Over the past year, MDGL quarterly D&A has increased by +$211.00 thousand (+125.60%).
  • MDGL quarterly D&A is now -56.88% below its all-time high of $879.00 thousand, reached on December 31, 2007.

Performance

MDGL quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

TTM D&A:

$1.31M+$211.00K(+19.25%)
March 31, 2025

Summary

  • As of today (June 21, 2025), MDGL TTM depreciation & amortization is $1.31 million, with the most recent change of +$211.00 thousand (+19.25%) on March 31, 2025.
  • Over the past year, MDGL TTM D&A has increased by +$736.00 thousand (+128.90%).
  • MDGL TTM D&A is now -61.00% below its all-time high of $3.35 million, reached on December 31, 2007.

Performance

MDGL TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

MDGL Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+108.0%+125.6%+128.9%
3 y3 years+170.6%+254.2%+227.6%
5 y5 years+878.6%+203.2%+525.4%

MDGL Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+170.6%at high+254.2%at high+227.6%
5 y5-yearat high+878.6%at high+325.8%at high+525.4%
alltimeall time-70.0%>+9999.0%-56.9%+212.5%-61.0%+487.8%

MDGL Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$379.00K(+4.4%)
$1.31M(+19.3%)
Dec 2024
$1.10M(+108.0%)
$363.00K(+21.8%)
$1.10M(+25.3%)
Sep 2024
-
$298.00K(+11.6%)
$875.00K(+22.9%)
Jun 2024
-
$267.00K(+58.9%)
$712.00K(+24.7%)
Mar 2024
-
$168.00K(+18.3%)
$571.00K(+8.3%)
Dec 2023
$527.00K(+12.8%)
$142.00K(+5.2%)
$527.00K(+2.5%)
Sep 2023
-
$135.00K(+7.1%)
$514.00K(+2.8%)
Jun 2023
-
$126.00K(+1.6%)
$500.00K(+3.3%)
Mar 2023
-
$124.00K(-3.9%)
$484.00K(+3.6%)
Dec 2022
$467.00K(+15.3%)
$129.00K(+6.6%)
$467.00K(+5.2%)
Sep 2022
-
$121.00K(+10.0%)
$444.00K(+5.7%)
Jun 2022
-
$110.00K(+2.8%)
$420.00K(+5.3%)
Mar 2022
-
$107.00K(+0.9%)
$399.00K(-1.5%)
Dec 2021
$405.00K(-14.0%)
$106.00K(+9.3%)
$405.00K(-2.4%)
Sep 2021
-
$97.00K(+9.0%)
$415.00K(-4.2%)
Jun 2021
-
$89.00K(-21.2%)
$433.00K(-5.7%)
Mar 2021
-
$113.00K(-2.6%)
$459.00K(-2.5%)
Dec 2020
$471.00K(+320.5%)
$116.00K(+0.9%)
$471.00K(+23.0%)
Sep 2020
-
$115.00K(0.0%)
$383.00K(+29.4%)
Jun 2020
-
$115.00K(-8.0%)
$296.00K(+41.6%)
Mar 2020
-
$125.00K(+346.4%)
$209.00K(+86.6%)
Dec 2019
$112.00K(+16.7%)
$28.00K(0.0%)
$112.00K(+2.8%)
Sep 2019
-
$28.00K(0.0%)
$109.00K(+3.8%)
Jun 2019
-
$28.00K(0.0%)
$105.00K(+4.0%)
Mar 2019
-
$28.00K(+12.0%)
$101.00K(+5.2%)
Dec 2018
$96.00K(+24.7%)
$25.00K(+4.2%)
$96.00K(-26.7%)
Sep 2018
-
$24.00K(0.0%)
$131.00K(+12.9%)
Jun 2018
-
$24.00K(+4.3%)
$116.00K(+16.0%)
Mar 2018
-
$23.00K(-61.7%)
$100.00K(+29.9%)
Dec 2017
$77.00K(>+9900.0%)
$60.00K(+566.7%)
$77.00K(+352.9%)
Sep 2017
-
$9000.00(+12.5%)
$17.00K(+112.5%)
Jun 2017
-
$8000.00(>+9900.0%)
$8000.00(>+9900.0%)
Mar 2017
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2016
-
$0.00(0.0%)
-$337.00K(<-9900.0%)
Dec 2015
$0.00
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2015
-
-$337.00K(-300.6%)
$169.00K(-74.9%)
DateAnnualQuarterlyTTM
Jun 2015
-
$168.00K(-0.6%)
$673.00K(-0.1%)
Mar 2015
-
$169.00K(0.0%)
$674.00K(+0.1%)
Dec 2014
$673.00K(+30.4%)
$169.00K(+1.2%)
$673.00K(+4.0%)
Sep 2014
-
$167.00K(-1.2%)
$647.00K(+3.0%)
Jun 2014
-
$169.00K(+0.6%)
$628.00K(+7.5%)
Mar 2014
-
$168.00K(+17.5%)
$584.00K(+13.2%)
Dec 2013
$516.00K(-30.1%)
$143.00K(-3.4%)
$516.00K(+5.7%)
Sep 2013
-
$148.00K(+18.4%)
$488.00K(-4.3%)
Jun 2013
-
$125.00K(+25.0%)
$510.00K(-16.1%)
Mar 2013
-
$100.00K(-13.0%)
$608.00K(-17.6%)
Dec 2012
$738.00K(-49.6%)
$115.00K(-32.4%)
$738.00K(-19.3%)
Sep 2012
-
$170.00K(-23.8%)
$914.00K(-16.5%)
Jun 2012
-
$223.00K(-3.0%)
$1.09M(-12.8%)
Mar 2012
-
$230.00K(-21.0%)
$1.25M(-14.3%)
Dec 2011
$1.46M(-24.3%)
$291.00K(-16.9%)
$1.46M(-10.5%)
Sep 2011
-
$350.00K(-8.9%)
$1.64M(-7.0%)
Jun 2011
-
$384.00K(-12.5%)
$1.76M(-5.3%)
Mar 2011
-
$439.00K(-5.2%)
$1.86M(-3.9%)
Dec 2010
$1.93M(-21.5%)
$463.00K(-2.1%)
$1.93M(-2.6%)
Sep 2010
-
$473.00K(-1.9%)
$1.99M(-6.2%)
Jun 2010
-
$482.00K(-6.4%)
$2.12M(-7.4%)
Mar 2010
-
$515.00K(0.0%)
$2.29M(-7.2%)
Dec 2009
$2.46M(-9.3%)
$515.00K(-14.7%)
$2.46M(-6.3%)
Sep 2009
-
$604.00K(-7.2%)
$2.63M(-4.5%)
Jun 2009
-
$651.00K(-6.1%)
$2.75M(+0.8%)
Mar 2009
-
$693.00K(+1.6%)
$2.73M(+0.6%)
Dec 2008
$2.72M(-18.9%)
$682.00K(-6.4%)
$2.72M(-6.8%)
Sep 2008
-
$729.00K(+16.1%)
$2.91M(-3.2%)
Jun 2008
-
$628.00K(-7.4%)
$3.01M(-6.8%)
Mar 2008
-
$678.00K(-22.9%)
$3.23M(-3.6%)
Dec 2007
$3.35M(-8.3%)
$879.00K(+6.4%)
$3.35M(+35.6%)
Sep 2007
-
$826.00K(-2.6%)
$2.47M(+50.2%)
Jun 2007
-
$848.00K(+6.3%)
$1.65M(+106.3%)
Mar 2007
-
$798.00K(+85.6%)
$798.00K(+85.6%)
Dec 2006
$3.65M(+48.9%)
-
-
Dec 2005
$2.46M(+58.7%)
-
-
Mar 2005
-
$430.00K
$430.00K
Dec 2004
$1.55M(+53.8%)
-
-
Dec 2003
$1.01M
-
-

FAQ

  • What is Madrigal Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals annual D&A year-on-year change?
  • What is Madrigal Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly D&A year-on-year change?
  • What is Madrigal Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals TTM D&A year-on-year change?

What is Madrigal Pharmaceuticals annual depreciation & amortization?

The current annual D&A of MDGL is $1.10M

What is the all time high annual D&A for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual depreciation & amortization is $3.65M

What is Madrigal Pharmaceuticals annual D&A year-on-year change?

Over the past year, MDGL annual depreciation & amortization has changed by +$569.00K (+107.97%)

What is Madrigal Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of MDGL is $379.00K

What is the all time high quarterly D&A for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly depreciation & amortization is $879.00K

What is Madrigal Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, MDGL quarterly depreciation & amortization has changed by +$211.00K (+125.60%)

What is Madrigal Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of MDGL is $1.31M

What is the all time high TTM D&A for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high TTM depreciation & amortization is $3.35M

What is Madrigal Pharmaceuticals TTM D&A year-on-year change?

Over the past year, MDGL TTM depreciation & amortization has changed by +$736.00K (+128.90%)
On this page